Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning
- PMID: 27885893
- DOI: 10.1148/rg.2017160054
Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning
Abstract
Treatment of pancreatic ductal adenocarcinoma (PDAC) remains a challenge, given its propensity for early systemic spread and growth into the adjacent vital vascular structures. With the advent of newer surgical techniques and chemoradiation therapies, multidetector computed tomography (CT) plays a crucial role in the identification of patients with borderline resectable disease who may benefit from such treatments. Stage III PDAC is divided into two categories-locally advanced, defined by arterial encasement or nonreconstructible portovenous axis involvement; and borderline resectable, defined by limited arterial involvement and/or reconstructible portovenous involvement. A consensus definition for stage III borderline resectable PDAC has been proposed by the Americas Hepato-Pancreato-Biliary Association, the Society of Surgical Oncology, and the Society for Surgery of the Alimentary Tract and has gained widespread use. Evaluation of borderline resectable disease involves the identification of the circumferential and longitudinal relationship of the tumor with its neighboring vessels, markers of vascular invasion, and aberrant anatomic structures that alter the surgical approach. Furthermore, the use of template-based radiology reporting may increase the objectivity of the evaluation and mandate the provision of all of the key descriptors required for a comprehensive evaluation of the disease. In this review, the staging of PDAC at multidetector CT is described, with reference to the evaluation of the tumor-vessel interface as it guides treatment planning, along with a discussion of the key descriptors of PDAC at multidetector CT and their importance. Examples are provided of the imaging findings of borderline resectable disease and different surgical approaches, along with a discussion on the importance of standardized terminology and template-based reporting. ©RSNA, 2016.
Comment in
-
Invited Commentary on "Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT," with Response from Dr Zaky and Colleagues.Radiographics. 2017 Jan-Feb;37(1):113-115. doi: 10.1148/rg.2017160205. Radiographics. 2017. PMID: 28076018 No abstract available.
Similar articles
-
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.Abdom Radiol (NY). 2020 Mar;45(3):716-728. doi: 10.1007/s00261-019-02289-5. Abdom Radiol (NY). 2020. PMID: 31748823 Review.
-
Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour-vascular interface in correlation with surgical and pathological outcomes.Clin Radiol. 2018 Mar;73(3):321.e1-321.e10. doi: 10.1016/j.crad.2017.11.001. Epub 2017 Dec 6. Clin Radiol. 2018. PMID: 29221719
-
Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.Abdom Radiol (NY). 2018 Feb;43(2):301-313. doi: 10.1007/s00261-017-1410-2. Abdom Radiol (NY). 2018. PMID: 29198002 Review.
-
Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.AJR Am J Roentgenol. 2020 Feb;214(2):362-369. doi: 10.2214/AJR.19.21152. Epub 2019 Dec 4. AJR Am J Roentgenol. 2020. PMID: 31799875 Free PMC article. Clinical Trial.
-
Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery.J Comput Assist Tomogr. 2017 May/Jun;41(3):394-400. doi: 10.1097/RCT.0000000000000530. J Comput Assist Tomogr. 2017. PMID: 27798447
Cited by
-
Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma.Front Oncol. 2020 Nov 16;10:523543. doi: 10.3389/fonc.2020.523543. eCollection 2020. Front Oncol. 2020. PMID: 33282722 Free PMC article.
-
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Diagnostics (Basel). 2020 Dec 3;10(12):1042. doi: 10.3390/diagnostics10121042. Diagnostics (Basel). 2020. PMID: 33287195 Free PMC article. Review.
-
PACT-UK (PAncreatic Cancer reporting Template-UK): a cross-specialty multi-institutional consensus panel development of a standardised radiological reporting proforma for pancreatic cancer.BMJ Oncol. 2023 Nov 20;2(1):e000055. doi: 10.1136/bmjonc-2023-000055. eCollection 2023. BMJ Oncol. 2023. PMID: 39886489 Free PMC article.
-
CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.Radiology. 2021 Dec;301(3):610-622. doi: 10.1148/radiol.2021210699. Epub 2021 Sep 7. Radiology. 2021. PMID: 34491129 Free PMC article.
-
Pancreatic Cancer Resectability After Neoadjuvant Treatment: An Imaging Challenge.Diagnostics (Basel). 2025 Jul 18;15(14):1810. doi: 10.3390/diagnostics15141810. Diagnostics (Basel). 2025. PMID: 40722559 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical